They noted that while the prior study involved patients referred to a single major medical center in a city with a high degree of medical sophistication, our study included individuals from a more general clinical setting. Additionally, they pointed out that differences in population characteristics and drug prescription preferences between single institutions and global databases may contribute to varying results, as can differences in healthcare systems across regions and countries
Faillie JL, Yin H, Yu OHY, et al
PlexusDx testing supports a more personalized conversation about whether semaglutide aligns with your unique genetic and clinical profile
Same molecule but different expression: aging and sepsis trigger NLRP3 inflammasome activation, a target of melatonin
Hellman, and Kelly Fennemore, MSN, ARNP, compound peptides for therapy to meet each patients unique healthcare needs
In both groups the mean age and diseases duration resulted higher than the overall population of the main RCT studies [25, 26], which could derive from an older diabetic population in Italy than in other countries [27]